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David R. Holmes, Jr, Dhanunjaya R. Lakkireddy, Richard P. Whitlock, Ron Waksman, Michael J. Mack
Despite the use of oral anticoagulants, stroke prevention in patients with atrial ﬁbrillation
remains challenging. Furthermore, a signiﬁcant number of patients are not candidates for
anticoagulation therapy, leaving them at signiﬁcant risk for stroke. In this state-of-the-art
paper, Holmes and colleagues review the current status of both surgical and catheter-based
left atrial appendage (LAA) closure devices. Results of trials comparing LAA closure devices
to anticoagulation therapy are reviewed. Additionally, the challenges faced in obtaining
regulatory approval for these devices are discussed.CLINICAL RESEARCH INTERVENTIONAL CARDIOLOGYDurable Versus Bioabsorbable Polymer DES 299
Tullio Palmerini, Giuseppe Biondi-Zoccai, Diego Della Riva, Andrea Mariani, Manel Sabaté,
Pieter C. Smits, Christoph Kaiser, Fabrizio D’Ascenzo, Giacomo Frati, Massimo Mancone,
Philippe Genereux, Gregg W. Stone
The authors investigate the relative safety and efﬁcacy of bioabsorbable polymer (BP)–based
biolimus-eluting stents (BES) versus durable-polymer drug-eluting stents (DES) and bare-
metal stents (BMS) using network meta-analysis. Data from 89 trials including 85,490
patients were analyzed. Results revealed that BP-BES were associated with superior clinical
outcomes compared with BMS and ﬁrst-generation DES, similar rates of cardiac death/
myocardial infarction (MI), MI, and target vessel revascularization compared with second-
generation BP-BES, but higher rates of deﬁnite stent thrombosis than Cobalt-chromium
everolimus-eluting stents.
Editorial Comment: John A. Bittl, p. 308(continued on page A-27)
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Femi Philip, Heather L. Gornik, Jeevanantham Rajeswaran, Eugene H. Blackstone, Mehdi H. Shishehbor
The impact of atherosclerotic renal artery stenosis (ARAS) on acute kidney injury (AKI) after
open-heart surgery (OHS) is unknown. The aim of this study was to further investigate the
signiﬁcance of this association. A total of 714 patients (mean age of 67  12 years)
undergoing OHS also had renal duplex ultrasound performed. The average glomerular
ﬁltration rate (GFR) was 52  25.9 ml/min/1.73 m2, and 206 (29%) subjects had ARAS.
Adjusted models showed a nonsigniﬁcant trend between ARAS and reduction in GFR post-
surgery. ARAS was also not associated with a need for renal replacement therapy, longer
length of stay (LOS), or mortality; however, a lower pre-operative GFR was a strong
predictor of long-term mortality independent of ARAS. Philip and colleagues conclude that
ARAS does not appear to be associated with post-operative changes in GFR, need for
hemodialysis, longer LOS, or mortality in patients undergoing OHS.
Editorial Comment: Giuseppe Biondi-Zoccai, Massimo Mancone, Giacomo Frati, p. 317ANTITHROMBOTIC THERAPYDabigatran Exposure Response in AF Patients 321Paul A. Reilly, Thorsten Lehr, Sebastian Haertter, Stuart J. Connolly, Salim Yusuf,
John W. Eikelboom, Michael D. Ezekowitz, Gerhard Nehmiz, Susan Wang, Lars Wallentin,
on behalf of the RE-LY Investigators
This study analyzed the impact of dabigatran plasma concentration, patient demographics,
and aspirin (ASA) use on the frequency of ischemic strokes/systemic emboli and major bleeds
in patients with atrial ﬁbrillation. Plasma concentrations of dabigatran were determined in
9,183 patients (from the RE-LY [Randomized Evaluation of Long-Term Anticoagulation
Therapy] trial) treated with dabigatran etexilate 110 or 150 mg twice daily. A total of
112 ischemic stroke/systemic emboli (1.3%) and 323 major bleeds (3.8%) were recorded.
Dabigatran levels were dependent on renal function, age, weight, and female sex. A multiple
logistic regression model (c-statistic: 0.657) showed that the risk of ischemic events was
inversely related to trough dabigatran concentration, with age and previous stroke as
signiﬁcant covariates. Major bleeding risk increased with dabigatran exposure, with age,
aspirin use, and diabetes as signiﬁcant covariates. Reilly and colleagues conclude that ischemic
stroke and bleeding outcomes were correlated with dabigatran plasma concentrations, with
age as the most important covariate.(continued on page A-28)
FEBRUARY 4, 2014 (continued) A-28CARDIAC IMAGINGUse of PET in Cardiac Sarcoidosis 329Ron Blankstein, Michael Osborne, Masanao Naya, Alfonso Waller, Chun K. Kim,
Venkatesh L. Murthy, Pedram Kazemian, Raymond Y. Kwong, Michifumi Tokuda, Hicham Skali,
Robert Padera, Jon Hainer, William G. Stevenson, Sharmila Dorbala, Marcelo F. Di Carli
The investigators of this study attempted to correlate image ﬁndings on positron emission
tomography (PET) to adverse cardiac events in patients referred for evaluation of known or
suspected cardiac sarcoidosis (CS). A total of 118 consecutive patients, with no history of
coronary artery disease, who were referred for PET using 18F-ﬂuorodeoxyglucose (FDG)
(to assess for inﬂammation) and 82Rubidium (to evaluate for perfusion defects [PD]) were
followed. Among the 118 patients (age 52  11 years; 57% male, mean ejection fraction 47 
16%), 47 (40%) had normal and 71 (60%) abnormal cardiac PET ﬁndings. Over a median
follow-up of 1.5 years, there were 31 (26%) adverse events (27 ventricular tachycardia [VT]
and 8 deaths). Cardiac PET ﬁndings were predictive of adverse events, with the presence of
both a PD and abnormal FDG (29% of patients) being associated with a hazard ratio of 3.9,
which was signiﬁcant even after adjusting for left ventricular ejection fraction and clinical
criteria. Blankstein and colleagues conclude that the presence of focal PD and FDG uptake
on cardiac PET identiﬁes patients at high risk of death or VT.CARDIAC IMAGINGPrognostic Impact of DSE in Kawasaki Disease 337
Nobutaka Noto, Hiroshi Kamiyama, Kensuke Karasawa, Mamoru Ayusawa, Naokata Sumitomo,
Tomoo Okada, Shori Takahashi
Noto and colleagues of this study sought to determine the prognostic value of dobutamine
stress echocardiography (DSE) for predicting cardiac events in adolescent Kawasaki disease
(KD) patients with coronary artery lesions (CALS). A total of 58 KD patients, including
36 patients with CALS documented by quantitative coronary angiography and 22 patients
with normal coronary artery documented by echocardiography, who underwent DSE were
reviewed at initial testing (mean age 13.6 years) and at 15-year follow-up. During a mean
follow-up of 14.7 years, there were 16 patients with major adverse cardiac events (MACE)
(acute myocardial infarction: n ¼ 1, old myocardial infarction: n ¼ 7, coronary artery bypass
grafting: n ¼ 4, percutaneous coronary intervention: n ¼ 4). Signiﬁcant coronary artery
disease (CAD) (>70% coronary stenosis) was detected in 31.0% patients at initial testing and
42.1% at follow-up. Five (85%) of 6 patients with false-positive DSE (wall motion score
index 1.25) at initial testing, who all had giant aneurysm without CAD, developed CAD
with MACE during follow-up. Cox regression analysis showed the grade of peak wall motion
score index at initial testing to be the only independent predictor of MACE. The authors
conclude that DSE provides independent prognostic information for up to 15 years in
adolescent KD survivors.(continued on page A-29)
FEBRUARY 4, 2014 (continued) A-29BIOMARKERS1-Year Change in Sensitive Troponin I and Coronary Events 345Harvey D. White, Andrew Tonkin, John Simes, Ralph Stewart, Kristy Mann, Peter Thompson,
David Colquhoun, Malcolm West, Paul Nestel, David Sullivan, Anthony C. Keech, David Hunt,
Stefan Blankenberg, for the LIPID Study Investigators
The objective of this study was to assess whether baseline and changes in the contemporary
sensitive (Siemens Ultra, Erlangen, Germany) troponin I (TnI) predict coronary heart disease
(CHD) and myocardial infarction (MI), and the effect of pravastatin on TnI levels and
relationship with outcomes. A total of 7,863 patients from the LIPID (Long-Term
Intervention with pravastatin in Ischemic Disease) study were included and had baseline and
1-year troponin levels measured. Median follow-up was 6 years. Baseline TnI tertiles were
<0.006, 0.006 to 0.018, and 0.018 mg/ml. TnI increased in 23%, was unchanged in
51.3%, and decreased in 25.7% of patients. Despite adjustment for 23 risk factors and
treatment, baseline levels of TnI were related to CHD deaths and MI (hazard ratio [HR]:
1.64). An increase in TnI was associated with increased CHD deaths and MI (HR: 1.31),
and a decrease in TnI was associated with a decreased risk (HR: 0.9). Pravastatin decreased
TnI levels by 0.003 ng/ml. The study concludes that baseline TnI levels and change at 1 year
are independent predictors of CHD death and MI. Troponin levels are strong predictors of
risk, and change modiﬁes risk.
Editorial Comment: Torbjørn Omland, p. 355CARDIAC GENETICS/GENOMICSCYB561 Gene and Heart Rate 358
Kuixing Zhang, Dekker C. Deacon, Fangwen Rao, Andrew J. Schork, Maple M. Fung,
Jill Waalen, Nicholas J. Schork, Caroline M. Nievergelt, Neil C. Chi, Daniel T. O’Connor
Zhang and colleagues attempt to understand the role of hereditary in the control of heart rate
(HR), focusing on cytochrome b561 (CYB561), by using a twin pair design at rest and during
environmental (cold) stress. Heritability was demonstrated for both basal/resting HR and
stress-augmented HR, and the 2 HRs shared genetic determination. CYB561 displayed
1 common genetic variant in the transcript region: A+1485G (rs3087776) in the 30 (downstream
of the open reading frame) untranslated region (UTR) (of the human CYB561 messenger
ribonucleic acid [RNA]). In a twin/sibling sample, G+1485A inﬂuenced HR, with the minor
(A) allele displaying a recessive effect. The effect of G+1485A on HR was extended by
meta-analysis into 2 additional population samples, and the inﬂuence remained directionally
consistent and signiﬁcant. G+1485A disrupted a microRNA (hsa-miR-1294) recognition
motif in the 30-UTR (with A>G allele matches). The authors conclude that HR is a
substantially heritable trait, with genetic inﬂuence by variation in the adrenergic pathway,
here shown for mRNA translational control at the CYB561 step of the transmitter formation.(continued on page A-30)
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Charlotte A. Pratt, Sonia Arteaga, Catherine Loria
In the past 30 years, the prevalence of obesity has more than doubled in children and tripled
in adolescents; more than 12 million (17%) U.S. children and adolescents are now obese.
Obese youth have a higher prevalence of vascular abnormalities, including left ventricular
hypertrophy and atherosclerosis, but also hypertension, dyslipidemia, and type 2 diabetes,
than normal-weight youth. There is a concern that obese children and adolescents will have a
higher incidence of heart disease as adults. In this paper, Pratt and colleagues describes the
ongoing National Heart, Lung and Blood Institute–initiated childhood obesity research.
Strategies for improving clinical care of obese children and adolescents are also discussed.
